tiprankstipranks
Advertisement
Advertisement
Ironwood Pharma Maintains Revolving Credit Facility to 2028
PremiumCompany AnnouncementsIronwood Pharma Maintains Revolving Credit Facility to 2028
2M ago
Ironwood price target raised to $10 from $8 at Citizens
Premium
The Fly
Ironwood price target raised to $10 from $8 at Citizens
2M ago
Ironwood Pharmaceuticals Balances Growth Plans With Pricing Risks
Premium
Company Announcements
Ironwood Pharmaceuticals Balances Growth Plans With Pricing Risks
2M ago
Ironwood upgraded to Buy from Hold at Craig-Hallum
PremiumThe FlyIronwood upgraded to Buy from Hold at Craig-Hallum
4M ago
Ironwood upgraded to Outperform from Market Perform at Citizens
Premium
The Fly
Ironwood upgraded to Outperform from Market Perform at Citizens
4M ago
Ironwood price target raised to $5 from $3 at Wells Fargo
Premium
The Fly
Ironwood price target raised to $5 from $3 at Wells Fargo
4M ago
Ironwood backs FY25 revenue view $290M-$310M, consensus $306.97M
PremiumThe FlyIronwood backs FY25 revenue view $290M-$310M, consensus $306.97M
4M ago
Ironwood sees FY26 revenue $450M-$475M, consensus $319.47M
Premium
The Fly
Ironwood sees FY26 revenue $450M-$475M, consensus $319.47M
4M ago
Ironwood Pharma Resolves Ferring Dispute, Amends License Terms
Premium
Company Announcements
Ironwood Pharma Resolves Ferring Dispute, Amends License Terms
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100